Overview
Specialty pharmaceutical company developing intranasal delivery formulations of psychedelic compounds including psilocybin and ketamine for rapid onset psychiatric treatment. Their proprietary nasal delivery technology improves bioavailability and dose precision.
More in Psychedelics
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 ยท Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 ยท Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 ยท Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 ยท Policy
Company details
Category
๐ Psychedelics
Location
San Diego, CA, USA
Funding
Seed ยท $4M
Website
neuronasal.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ